Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis. 1991

N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
Fourth Department of Internal Medicine, Toho University, Tokyo, Japan.

It is widely accepted that a long-term, alternate-day administration of adrenal corticosteroids after thymectomy is one of the most effective treatments of myasthenia gravis. However, some patients with myasthenia gravis show a tendency to develop steroid dependency, and require extremely prolonged administration of fairly high doses of steroids. Various types of adverse reactions to steroids are likely to occur in such cases. To avoid this, intermittent, single-dose administration of steroids was performed on a trial basis in the present study. Prednisolone, in doses of 50-100 mg, was given once every 3-7 days in three steroid-dependent myasthenic patients, in one case for up to 6 years. The effects of the intermittent treatment were as good as, and adverse effects less frequently found than in single-dose, alternate-day administration.

UI MeSH Term Description Entries
D008297 Male Males
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
January 1987, Annals of the New York Academy of Sciences,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
January 2002, Journal of clinical apheresis,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
February 1990, Postgraduate medical journal,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
November 2008, Deutsche medizinische Wochenschrift (1946),
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
February 1997, Journal of neurology, neurosurgery, and psychiatry,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
March 2005, Journal of neurology, neurosurgery, and psychiatry,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
November 2017, Therapeutic advances in neurological disorders,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
December 2002, Clinical neurology and neurosurgery,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
September 1975, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
N Wakata, and Y Kawamura, and M Kobayashi, and Y Araki, and M Kinoshita
December 1988, Annals of neurology,
Copied contents to your clipboard!